Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITLECITINIB for Alopecia universalis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 38 adverse event reports in the FDA FAERS database where RITLECITINIB was used for Alopecia universalis.

Most Reported Side Effects for RITLECITINIB

Side Effect Reports % Deaths Hosp.
Drug ineffective 259 18.0% 0 0
Therapeutic product effect incomplete 122 8.5% 0 0
Condition aggravated 85 5.9% 0 0
Off label use 82 5.7% 0 2
Headache 70 4.9% 0 1
Diarrhoea 49 3.4% 0 3
Product dose omission issue 45 3.1% 0 0
Alopecia 44 3.1% 0 0
Fatigue 36 2.5% 0 0
Urticaria 36 2.5% 0 1
Acne 35 2.4% 0 0
Pruritus 34 2.4% 0 0
Blood creatine phosphokinase increased 29 2.0% 0 1
Nausea 29 2.0% 0 1
Rash 29 2.0% 0 1

Other Indications for RITLECITINIB

Alopecia areata (670) Alopecia (147) Alopecia totalis (43) Alopecia scarring (10) Vitiligo (10) Lichen planopilaris (8) Product used for unknown indication (8) Androgenetic alopecia (6)

Other Drugs Used for Alopecia universalis

TOFACITINIB (264) BARICITINIB (66) METHOTREXATE (29) PREDNISOLONE (15) DUPILUMAB (14) MINOXIDIL (14) RUXOLITINIB (14) TRIAMCINOLONE ACETONIDE (10) APREMILAST (9) CYCLOSPORINE (9)

Related Pages

RITLECITINIB Full Profile All Alopecia universalis Drugs RITLECITINIB Demographics RITLECITINIB Timeline